Skip to main content
Elsevier

Applications of Artificial Intelligence in Healthcare

The Changing Landscape

  • 1st Edition - July 1, 2026
  • Latest edition
  • Editors: Debasis Bagchi, Samudra Prosad Banik, Anand Swaroop, Sunny Ohia
  • Language: English

Applications of Artificial Intelligence in Healthcare: The Changing Landscape takes a systematic approach, discussing the benefits and achievements of AI while also explor… Read more

Description

Applications of Artificial Intelligence in Healthcare: The Changing Landscape takes a systematic approach, discussing the benefits and achievements of AI while also exploring the questions and challenges of AI as it relates to health and medicine. The first section provides historical context, introducing the reader to the fundamentals of AI in health care. The second section addresses the primary applications of AI in healthcare, including chatbots for tele-counseling, telemedicine, and AI assisted prediction tools. The third section focuses on the use of robotics and AI driven precision instruments to carry out complex surgical procedures.

The fourth section highlights emerging AI assisted technologies for the management of diseases and disorders. The fifth section covers emerging applications of AI in medical science and holistic health management, for example ChatGPT and Natural Language Processing algorithms. Finally, the sixth section concludes with chapters dedicated to federal and regulatory issues of adopting AI as it relates to human health, along with the ethical issues and limitations.

Key features

  • Acquaints readers with the historical background of Artificial Intelligence while also connecting its limitless potential with healthcare
  • Presents advanced application of Artificial Intelligence across the multidisciplinary facets of healthcare
  • Provides guidelines on ethical issues and safety standards of computer applications in human society

Readership

Graduate students, researchers, clinical investigators, physicians especially neurologists and others involved in AI assisted diagnostics, neurotoxicologists, pharmacologists, pharmacists, health professionals, and practitioners, nurses and general practitioners, and public health officials

Table of contents

Section 1: Introduction to AI and Healthcare

1. Introduction to Fundamentals of AI Application in Healthcare

2. Bottlenecks in Medical Science: Why do We Need the Interventions of AI

3. Fuzzy Rule-based Systems for Disease Diagnosis

4. The Potential of Quantum AI in Augmentation of Human Health

Section 2: The Role of AI in Holistic Healthcare and Disease Diagnosis

5. State-of-the-Art AI Assisted Disease Detection Tools

6. AI in Biomedical Image Processing

7. Use of AI Chatbots for Primary Diagnosis at Home

8. AI Assisted Imaging Technologies for Disease Diagnosis

9. AI for Detection and Arrest of Infectious Diseases

10. Understanding Key Algorithms for Construction of AI Assisted Prediction Tools

11. Minimizing Vulnerability of AI Programmes from Cyber-attacks

Section 3: Use of AI in Organ Transplantation and Precision Surgery

12. Predictive AI to Increase Success of Heart Transplantation

13. AI Assisted Augmented Reality Overlay in Precision Surgeries

14. AI Driven Robotics in Neurosurgery

15. AI in Minimally Invasive Surgeries

16. AI in Cosmetic Surgery

Section 4: Domain Specific Applications in Medical Science through AI Intervention

17. Use of AI in Assisted Reproduction

18. AI for Management of Cardiovascular Diseases

19. AI in Telemedicine: The Evolution of Virtual Ophthalmology

20. The Role of Machine Learning in Autoimmune Disease Prediction

21. AI in Psychotherapy and Counseling

22. AI in Detecting and Mitigation of Neurological Disease

23. AI in Remote Monitoring of Patients

Section 5: New Frontiers of AI

24. The Evolution of ChatGPT in AI Assisted Biomedical Care

25. Role of Generative AI in Drug Designing, Toxicity Assessment and Bio-diversity

26. AI-based Predictive Models for Nutraceutical and Functional Food Industry

27. AI-enabled Organoids for Clinical Applications

28. Medicinal Plant Isolates

Section 6: Conclusion: The Future of AI

29. Regulatory, Federal, and Ethical Issues of AI in Biomedical Applications

30. Commentary: The Evolution of AI and its Implications for Future Human Generation

Product details

  • Edition: 1
  • Latest edition
  • Published: July 1, 2026
  • Language: English

About the editors

DB

Debasis Bagchi

Debasis Bagchi earned his Ph.D. in Medicinal Chemistry in 1982 and is a Professor in the Department of Pharmacological and Pharmaceutical Sciences at the University of Houston College of Pharmacy. He also serves as Chief Scientific Officer at Cepham Research Center and holds adjunct faculty appointments. Previously, he was Senior Vice President of Research & Development at InterHealth Nutraceuticals (1998–2011) and later Director of Innovation and Clinical Affairs at Iovate Health Sciences (2011–2013).

Dr. Bagchi received the Master of the American College of Nutrition Award in 2010 and has held leadership roles including Past President of the American College of Nutrition and Past Chairman of the International Society of Nutraceuticals and Functional Foods. He contributes as an NIH peer reviewer and advisor to international health organizations.

A prolific scholar, he has authored over 320 peer-reviewed papers, 30 books, and holds 18 patents. He also serves on editorial boards of numerous scientific journals.

Affiliations and expertise
Professor, Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, USA; Chief Scientific Officer, Cepham Research Center, Piscataway, New Jersey; Adjunct Faculty, Texas Southern University, Houston, Texas, USA

SB

Samudra Prosad Banik

Samudra Prosad Banik, Ph.D., received his PhD degree in Life Sciences from Jadavpur University in 2009 after working in the field of Fungal Biotechnology from the CSIR –Indian Institute of Chemical Biology, Kolkata, India. Dr. Banik is currently working as Assistant Professor at the Department of Microbiology, Maulana Azad College, University of Calcutta at Kolkata, India. After completing his Masters in Biophysics and Molecular Biology at the University of Kolkata in 2003, Dr. Banik was awarded a travel grant to work in a short project of genetically engineered rice with increased photosynthetic efficiency at International Rice Research Institute, Philippines. Thereafter he completed his PhD. at IICB where he identified an alternative pathway of vesicles mediated protein secretion in filamentous fungus, and performed biophysical characterization of the glycosylated fungal enzyme assemblies. Upon joining Maulana Azad College, Dr. Banik continued his research on behavior of glycosylated/glycated proteins in higher eukaryotes. In the process, he eventually shifted his attention towards glycated proteins formed during hyperglycemia and its associated consequences chiefly with regards to neuronal disorders. He has been the recipient of three research projects and has published more than 32 research articles in SCOPUS/Web of Science indexed journals along with 15 book chapters published by CRC Press/Wiley/CRC Press. Dr. Banik has edited one book on Biofuels which is scheduled to come out early next year from CRC Press/Taylor and Francis. He is an active reviewer of significant journals including Heliyon, PLOS One and Journal of American Nutrition Association. He is presently the Joint-Convenor of Research Committee at Maulana Azad College. His current research interests include understanding the mechanism of stabilization of proteins by osmolytes as well as structural changes inflicted in proteins due to glycation.

Affiliations and expertise
Department of Microbiology, Maulana Azad College, India

AS

Anand Swaroop

Anand Swaroop is a trained scientist turned entrepreneur with a rich background in biochemistry. After spending a decade in various positions in the pharmaceutical sector, he began exploring natural product chemistry. Over the last three decades, Dr. Swaroop has earned diversified global management experience in the Natural Products business. His expertise includes natural product chemistry, research, supply chain management, and strategic planning. His diverse experience in research, quality assurance, product development, manufacturing, and marketing has given him a unique and multidisciplinary perspective on the industry. In 2016, he was selected as a Fellow of the American College of Nutrition. He's also a member of the task force constituted by the Government of India in 2021 to recommend the development of the Nutraceutical Sector in India and worldwide for Ayurvedic products. Currently he's the Founder President of reputable companies, including Cepham Inc., Nutrify Today, and Cepham Life Sciences Inc.
Affiliations and expertise
Research and Development, Cepham Inc., Somerset, NJ, USA

SO

Sunny Ohia

Sunny Ohia is a Professor of Pharmacology in the College of Pharmacy and Health Sciences at Texas Southern University. Dr. Ohia has over 38 years of experience in higher education having served as a member of faculty in five universities in Canada and the United States. He holds other academic appointments as adjunct professor of ophthalmology and visual sciences at the University of Nebraska Medical Center, Omaha and as an adjunct professor of integrative biology and pharmacology at the University of Texas Health Sciences Center in Houston. Dr. Ohia is a Fellow of the Nigerian Academy of Science and a Fellow of the Association for Research in Vision and Ophthalmology. He's authored over 250 original papers, book chapters, books, and abstracts and, holds three U.S. and five international Patents for his scientific work.
Affiliations and expertise
Professor, College of Pharmacy and Health Sciences, Texas Southern University, Houston, TX, USA